Advances and applications of induced pluripotent stem cells

Canadian Journal of Physiology and Pharmacology

Volumn 90, Issue 3, 2012, Pages 317-325

  Pietronave, Stefano ^a   Prat, Maria ^b  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b Centro di Biotecnologie per la Ricerca Medica Applicata (BRMA)   (Italy)

Author keywords

Drug discovery; Ips; Regenerative medicine; Retrovirus

Indexed keywords

ADENOVIRUS VECTOR; MESSENGER RNA; MICRORNA; TRANSCRIPTION FACTOR;

ARTICLE; DRUG DEVELOPMENT; DRUG RESEARCH; EPISOME; FIBROBLAST; GENOMICS; HUMAN; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGENERATIVE MEDICINE; RNA VIRUS; TRANSPOSON; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; ANIMALS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MICRORNAS; PLASMIDS;

EID: 84858023837     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/y11-125     Document Type: Article

References (83)

1. Aasen, T., Raya, A., Barrero, M.J., Garreta, E., Consiglio, A., Gonzalez, F., et al. 2008. Efficient and rapid generation of induced pluripotent stem cells from human keratinocyte. Nat. Biotechnol. 26(11): 1276-1284. doi:10.1038/nbt.1503.
2. Anokye-Danso, F., Trivedi, C.M., Juhr, D., Gupta, M., Cui, Z., Tian, Y., et al. 2011. Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell, 8(4): 376-388. doi:10.1016/j.stem.2011.03.001.
3. Aoi, T., Yae, K., Nakagawa, M., Ichisaka, T., Okita, K., Takahashi, K., et al. 2008. Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science, 321(5889): 699-702. doi:10.1126/science.1154884.
4. Aoki, T., Ohnishi, H., Oda, Y., Tadokoro, M., Sasao, M., Kato, H., et al. 2010. Generation of induced pluripotent stem cells from human adipose-derived stem cells without c-MYC. Tissue Eng. Part A, 16 (7): 2197-2206. doi:10.1089/ten.tea.2009.0747.
5. Asgari, S., Pournasr, B., Salekdeh, G.H., Ghodsizadeh, A., Ott, M., and Baharvand, H. 2010. Induced pluripotent stem cells: a new era for hepatology. J. Hepatol. 53(4): 738-751. doi:10.1016/j.jhep.2010.05.009.
6. Bar-Nur, O., Russ, H.A., Efrat, S., and Benvenisty, N. 2011. Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells. Cell Stem Cell. 9: 17-23. doi:10.1016/j.stem.2011.06.007.
7. Boulting, G.L., Kiskinis, E., Croft, G.F., Amoroso, M.W., Oakley, D. H., Wainger, B.J., et al. 2011. A functionally characterized test set of human induced pluripotent stem cells. Nat. Biotechnol. 29(3): 279-286. doi:10.1038/nbt.1783.
8. Briggs, R., and King, T.J. 1952. Transplantation of living nuclei from blastula cells into enucleated frogs' eggs. Proc. Natl. Acad. Sci. U.S. A. 38(5): 455-463. doi:10.1073/pnas.38.5.455.
9. Chang, H.M., and Gregory, R.I. 2011. MicroRNAs and reprogramming. Nat. Biotechnol. 29(6): 499-500. doi:10.1038/nbt.1889.
10. Chang, C.W., Lai, Y.S., Pawlik, K.M., Liu, K., Sun, C.W., Li, C., et al. 2009. Polycistronic lentiviral vector for "hit and run" reprogramming of adult skin fibroblasts to induced pluripotent stem cells. Stem Cells, 27(5): 1042-1049. doi:10.1002/stem.39.
11. Chou, B.K., Mali, P., Huang, X., Ye, Z., Dowey, S.N., Resar, L.M.S., et al. 2011. Efficient human iPS cell derivation by a nonintegrating plasmid from blood cells with unique epigenetic and gene expression signatures. Cell Res. 21(3): 518-529. doi:10. 1038/cr.2011.12.
12. Cohen, D.E., and Melton, D. 2011. Turning straw into gold: directing cell fate for regenerative medicine. Nat. Rev. Genet. 12(4): 243-252. doi:10.1038/nrg2938.
13. Davis, R.L., Weintraub, H., and Lassar, A.B. 1987. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell, 51(6): 987-1000. doi:10.1016/0092-8674(87)90585-X3690668.
14. Dimos, J.T., Rodolfa, K.T., Niakan, K.K., Weisenthal, L.M., Mitsumoto, H., Chung, W., et al. 2008. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science, 321(5893): 1218-1221. doi:10.1126/science.1158799.
15. Ding, S., Wu, X., Li, G., Han, M., Zhuang, Y., and Xu, T. 2005. Efficient transposition of the piggyBac (PB) transposon in mammalian cells and mice. Cell, 122(3): 473-483. doi:10.1016/j.cell.2005.07.013.
16. Ebert, A.D., Yu, J., Rose, F.F., Jr, Mattis, V.B., Lorson, C.L., Thomson, J.A., and Svendsen, C.N. 2009. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature, 457 (7227): 277-280. doi:10.1038/nature07677.
17. Eminli, S., Utikal, J., Arnold, K., Jaenisch, R., and Hochedlinger, K. 2008. Reprogramming of neural progenitor cells into induced pluripotent stem cells in the absence of exogenous Sox2 expression. Stem Cells, 26(10): 2467-2474. doi:10.1634/stemcells.2008-0317.
18. Feng, R., Desbordes, S.C., Xie, H., Tillo, E.S., Pixley, F., Stanley, E.R., and Graf, T. 2008. PU.1 and C/EBPa/b convert fibroblasts into macrophage-like cells. Proc. Natl. Acad. Sci. U.S.A. 105(16): 6057-6062. doi:10.1073/pnas.0711961105.
19. Fox, J.L. 2011. Human iPSC and ESC translation potential debated. Nat. Biotechnol. 29(5): 375-376. doi:10.1038/nbt0511-375a.
20. Fraser, M.J., Ciszczon, T., Elick, T., and Bauser, C. 1996. Precise excision of TTAA-specific lepidopteran transposons piggyback (IFP2) and tagalong (TFP3) from the baculovirus genome in cell lines from two species of Lepidoptera. Insect Mol. Biol. 5(2): 141-151. doi:10.1111/j.1365-2583.1996.tb00048.x.
21. Fusaki, N., Ban, H., Nishiyama, A., Saeki, K., and Hasegawa, M. 2009. Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc. Jpn. Acad B Phys. Biol. Sci. 85(8): 348-362. doi:10.2183/pjab.85.348.
22. Gaspar-Maia, A., Alajem, A., Polesso, F., Sridharan, R., Mason, M.J., Heidersbach, A., et al. 2009. Chd1 regulates open chromatin and pluripotency of embryonic stem cells. Nature, 460(7257): 863-868.
23. Gaspar-Maia, A., Alajem, A., Meshorer, E., and Ramalho-Santos, M. 2011. Open chromatin in pluripotency and reprogramming. Nat. Rev. Mol. Cell Biol. 12(1): 36-47. doi:10.1038/nrm3036.21179060.
24. Gekas, C., and Graf, T. 2010. Induced pluripotent stem cell-derived human platelets: one step closer to the clinic. J. Exp. Med. 207 (13): 2781-2784. doi:10.1084/jem.20102428.
25. González, F., Barragan Monasterio, M., Tiscornia, G., Montserrat Pulido, N., Vassena, R., Batlle Morera, L., et al. 2009. Generation of mouse-induced pluripotent stem cells by transient expression of a single nonviral polycistronic vector. Proc. Natl. Acad. Sci. U.S. A. 106(22): 8918-8922. doi:10.1073/pnas.0901471106.19458047.
26. González, F., Boué, S., and Izpisúa Belmonte, J.C. 2011. Methods for making induced pluripotent stem cells: reprogramming à la carte. Nat. Rev. Genet. 12(4): 231-242. doi:10.1038/nrg2937.21339765.
27. Gore, A., Li, Z., Fung, H., Young, J.E., Agarwal, S., Antosiewicz-Bourget, J., et al. 2011. Somatic coding mutations in human induced pluripotent stem cells. Nature, 471(7336): 63-67. doi:10.1038/nature09805.
28. Hacein-Bey-Abina, S., Von Kalle, C., Schmidt, M., McCormack, M.P., Wulffraat, N., Leboulch, P., et al. 2003. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCIDX1. Science, 302(5644): 415-419. doi:10.1126/science.1088547.
29. Hanna, J., Wernig, M., Markoulaki, S., Sun, C.W., Meissner, A., Cassady, J.P., et al. 2007. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science, 318 (5858): 1920-1923. doi:10.1126/science.1152092.18063756.
30. Hanna, J., Markoulaki, S., Schorderet, P., Carey, B., Beard, C., Wernig, M., et al. 2008. Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency. Cell, 133(2): 250-264. doi:10.1016/j.cell.2008.03.028.
31. He, T.C., Zhou, S., da Costa, L.T., Yu, J., Kinzler, K.W., and Vogelstein, B. 1998. A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. U.S.A. 95(5): 2509-2514. doi:10.1073/pnas.95.5.2509.
32. Hong, H., Takahashi, K., Ichisaka, T., Aoi, T., Kanagawa, O., Nakagawa, M., et al. 2009. Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature, 460(7259): 1132-1135. doi:10.1038/nature08235.
33. Ieda, M., Fu, J.D., Delgado-Olguin, P., Vedantham, V., Hayashi, Y., Bruneau, B.G., and Srivastava, D. 2010. Direct reprogramming offibroblasts into functional cardiomyocytes by defined factors. Cell, 142(3): 375-386. doi:10.1016/j.cell.2010.07.002.
34. tzhaki, I., Maizels, L., Huber, I., Zwi-Dantsis, L., Caspi, O., Winterstern, A., et al. 2011. Modelling the long QT syndrome with induced pluripotent stem cells. Nature, 471(7337): 225-229. doi:10.1038/nature09747.
35. Kawamura, T., Suzuki, J., Wang, Y.V., Menendez, S., Morera, L.B., Raya, A., et al. 2009. Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature, 460(7259): 1140-1144.doi:10.1038/nature08311.
36. Kim, J.B., Greber, B., Araúzo-Bravo, M., Meyer, J., Park, K., Zaehres, H., and Schöler, H.R. 2009a. Direct reprogramming of human neural stem cells by OCT4. Nature, 461(7264): 649-653. doi:10.1038/nature08436.
37. Kim, D., Kim, C.H., Moon, J.I., Chung, Y.G., Chang, M.Y., Han, B.S., et al. 2009b. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell, 4(6): 472-476. doi:10.1016/j.stem.2009.05.005.19481515.
38. Kim, K., Doi, A., Wen, B., Ng, K., Zhao, R., Cahan, P., et al. 2010. Epigenetic memory in induced pluripotent stem cells. Nature, 467 (7313): 285-290. doi:10.1038/nature09342.
39. Kulessa, H., Frampton, J., and Graf, T. 1995. GATA-1 reprograms avian myelomonocytic cell lines into eosinophils, thromboblasts and erythroblasts. Genes Dev. 9(10): 1250-1262. doi:10.1101/gad.9.10.1250.
40. Lai, M.I., Wendy-Yeo, W.Y., Ramasamy, R., Nordin, N., Rosli, R., Veerakumarasivam, A., and Abdullah, S. 2011. Advancements in reprogramming strategies for the generation of induced pluripotent stem cells. J. Assist. Reprod. Genet. 28(4): 291-301. doi:10.1007/s10815-011-9552-6.
41. Lee, G., Papapetrou, E.P., Kim, H., Chambers, S.M., Tomishima, M.J., Fasano, C.A., et al. 2009. Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature, 461(7262): 402-406. doi:10.1038/nature08320.
42. Lee, C.H., Kim, J.H., Lee, H.J., Jeon, K., Lim, H., Choi, H.Y., et al. 2011. The generation of iPS cells using non-viral magnetic nanoparticlebased transfection. Biomaterials, 32(28): 6683-6691. doi:10.1016/j.biomaterials.2011.05.070.
43. Li, R., Liang, J., Ni, S., Zhou, T., Qing, X., Li, H., et al. 2010. A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts. Cell Stem Cell, 7 (1): 51-63. doi:10.1016/j.stem.2010.04.014.
44. Loh, Y.H., Agarwal, S., Park, I.H., Urbach, A., Huo, H., Heffner, G., et al. 2009. Generation of induced pluripotent stem cells from human blood. Blood, 113(22): 5476-5479. doi:10.1182/blood-2009-02-204800.
45. Maherali, N., Ahfeldt, T., Rigamonti, A., Utikal, J., Cowan, C., and Hochedlinger, K. 2008. A high-efficiency system for the generation and study of human induced pluripotent stem cells. Cell Stem Cell, 3(3): 340-345. doi:10.1016/j.stem.2008.08.003.
46. Malan, D., Friedrichs, S., Fleischmann, B.K., and Sasse, P. 2011. Cardiomyocytes obtained from induced pluripotent stem cells with long-QT syndrome 3 recapitulate typical disease-specific features in vitro. Circ. Res. 109(8): 841-847. doi:10.1161/CIRCRESAHA. 111.243139.
47. Moretti, A., Bellin, M., Welling, A., Jung, C.B., Lam, J.T., Bott-Flugel, L., et al. 2010. Patient-specific induced pluripotent stemcell models for long-QT syndrome. N. Engl. J. Med. 363(15): 1397-1409. doi:10.1056/NEJMoa0908679.
48. Morita, H., Wu, J., and Zipes, D.P. 2008. The QT syndromes: long and short. Lancet, 372(9640): 750-763. doi:10.1016/S0140-6736(08)61307-0.
49. Nakagawa, M., Yamanaka, S. 2010. Reprogramming of somatic cells to pluripotency. In The Cell Biology of Stem Cell. Edited by Eran Meshorer and Kathrine Plath. Landes Bioscences and Springer Science. pp. 215-224. Available from www.springer.com/life+sciences/book/978-1-4419-7036-7.
50. Nelson, T.J., Martinez-Fernandez, A., Yamada, S., Perez-Terzic, C., Ikeda, Y., and Terzic, A. 2009. Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation, 120(5): 408-416. doi:10.1161/CIRCULATIONAHA.109.865154.
51. Nishimura, K., Sano, M., Ohtaka, M., Furuta, B., Umemura, Y., Nakajima, Y., et al. 2011. Development of defective and persistent Sendai virus vector: a unique gene delivery/expression system ideal for cell reprogramming. J. Biol. Chem. 286(6): 4760-4771. doi:10.1074/jbc.M110.183780.
52. Okita, K., and Yamanaka, S. 2010. Induction of pluripotency by defined factors. Exp. Cell Res. 316(16): 2565-2570. doi:10.1016/j.yexcr.2010.04.023.
53. Okita, K., Nakagawa, M., Hyenjong, H., Ichisaka, T., and Yamanaka, S. 2008. Generation of mouse induced pluripotent stem cells without viral vectors. Science, 322(5903): 949-953. doi:10.1126/science.1164270.
54. Park, I.H., Arora, N., Huo, H., Maherali, N., Ahfeldt, T., Shimamura, A., et al. 2008. Disease specific induced pluripotent stem cells. Cell, 134(5): 877-886. doi:10.1016/j.cell.2008.07.041.8691744.
55. Plath, K., and Lowry, W.E. 2011. Progress in understanding reprogramming to the induced pluripotent state. Nat. Rev. Genet. 12(4): 253-265. doi:10.1038/nrg2955.
56. Plews, J.R., Li, J., Jones, M., Moore, H.D., Mason, C., Andrews, P.W., and Na, J. 2010. Activation of pluripotency genes in human fibroblast cells by a novel mRNA based approach. PLoS ONE, 5(12): e14397. doi:10.1371/journal.pone.0014397.21209933.
57. Polo, J.M., Liu, S., Figueroa, M.E., Kulalert, W., Eminli, S., Tan, K.Y., et al. 2010. Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat. Biotechnol. 28(8): 848-855. doi:10.1038/nbt.1667.
58. Ruiz, S., Brennand, K., Panopoulos, A.D., Herrerías, A., Gage, F.H., and Izpisua-Belmonte, J.C. 2010. High-efficient generation of induced pluripotent stem cells from human astrocytes. PLoS ONE, 5(12): e15526. doi:10.1371/journal.pone.0015526.
59. Scheper, W., and Copray, S. 2009. The molecular mechanism of induced pluripotency: a two-stage switch. Stem Cell Rev. 5(3): 204-223. doi:10.1007/s12015-009-9077-x.
60. Schneuwly, S., Klemenz, R., and Gehring, W.J. 1987. Redesigning the body plan of Drosophila by ectopic expression of the homoeotic gene Antennapedia. Nature, 325(6107): 816-818. doi:10.1038/325816a0.
61. Si-Tayeb, K., Noto, F.K., Sepac, A., Sedlic, F., Bosnjak, Z.J., Lough, J.W., and Duncan, S.A. 2010. Generation of human induced pluripotent stem cells by simple transient transfection of plasmid DNA encoding reprogramming factors. BMC Dev. Biol. 10(1): 81-90. doi:10.1186/1471-213X-10-81.
62. Smith, Z.D., Nachman, I., Regev, A., and Meissner, A. 2010. Dynamic single-cell imaging of direct reprogramming reveals an early specifying event. Nat. Biotechnol. 28(5): 521-526. doi:10. 1038/nbt.1632.
63. Stadtfeld, M., Maherali, N., Breault, D.T., and Hochedlinger, K. 2008a. Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse. Cell Stem Cell, 2(3): 230-240. doi:10.1016/j.stem.2008.02.001.
64. Stadtfeld, M., Nagaya, M., Utikal, J., Weir, G., and Hochedlinger, K. 2008b. Induced pluripotent stem cells generated without viral integration. Science, 322(5903): 945-949. doi:10.1126/science. 1162494.
65. Staerk, J., Dawlaty, M.M., Gao, Q., Maetzel, D., Hanna, J., Sommer, C.A., et al. 2010. Reprogramming of human pheripheral blood cells to induced pluripotent stem cells. Cell Stem Cell, 7(1): 20-24. doi:10.1016/j.stem.2010.06.002.
66. Subramanyam, D., Lamouille, S., Judson, R.L., Liu, J.Y., Bucay, N., Derynck, R., and Blelloch, R. 2011. Multiple targets of miR-302 and miR-372 promote reprogramming of human fibroblasts to induced pluripotent stem cells. Nat. Biotechnol. 29(5): 443-448. doi:10.1038/nbt.1862.
67. Sun, N., Panetta, N.J., Gupta, D.M., Wilson, D., Lee, A., Jia, F., et al. 2009. Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells. Proc. Natl. Acad. Sci. U.S.A. 106(37): 15720-15725. doi:10.1073/pnas.0908450106.
68. Tada, M., Takahama, Y., Abe, K., Nakatsuji, N., and Tada, T. 2001. Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells. Curr. Biol. 11(19): 1553-1558. doi:10.1016/S0960-9822(01)00459-6.
69. Takahashi, K., and Yamanaka, S. 2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126(4): 663-676. doi:10.1016/j.cell.2006.07.024.
70. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., and Yamanaka, S. 2007. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131(5): 861-872. doi:10.1016/j.cell.2007.11.019.
71. Utikal, J., Polo, J.M., Stadtfeld, M., Maherali, N., Kulalert, W., Walsh, R.M., et al. 2009. Immortalization eliminates a roadblock during cellular reprogramming into iPS cells. Nature, 460(7259): 1145-1148. doi:10.1038/nature08285.
72. Wakayama, T., Perry, A.C., Zuccotti, M., Johnson, K.R., and Yanagimachi, R. 1998. Full-term development of mice from enucleated oocytes injected with cumulus cell nuclei. Nature, 394 (6691): 369-374. doi:10.1038/28615.
73. Wang, W., Lin, C., Lu, D., Ning, Z., Cox, T., Melvin, D., et al. 2008. Chromosomal transposition of PiggyBac in mouse embryonic stem cells. Proc. Natl. Acad. Sci. U.S.A. 105(27): 9290-9295. doi:10.1073/pnas.0801017105.
74. Warren, L., Manos, P.D., Ahfeldt, T., Loh, Y.H., Li, H., Lau, F., et al. 2010. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell, 7(5): 618-630. doi:10.1016/j.stem.2010.08.012.
75. Wernig, M., Lengner, C.J., Hanna, J., Lodato, M.A., Steine, E., Foreman, R., et al. 2008a. A drug-inducible transgenic system for direct reprogramming of multiple somatic cell types. Nat. Biotechnol. 26(8): 916-924. doi:10.1038/nbt1483.
76. Wernig, M., Zhao, J.P., Pruszak, J., Hedlund, E., Fu, D., Soldner, F., et al. 2008b. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc. Natl. Acad. Sci. U.S.A. 105 (15): 5856-5861. doi:10.1073/pnas.0801677105.
77. Wilmut, I., Schnieke, A.E., McWhir, J., Kind, A.J., and Campbell, K.H. 1997. Viable offspring derived from fetal and adult mammalian cells. Nature, 385(6619): 810-813. doi:10.1038/385810a0.
78. Woltjen, K., Michael, I.P., Mohseni, P., Desai, R., Mileikovsky, M., Hämäläinen, R., et al. 2009. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature, 458(7239): 766-770. doi:10.1038/nature07863.
79. Xie, H., Ye, M., Feng, R., and Graf, T. 2004. Reprogramming of B cells into macrophages. Cell, 117(5): 663-676. doi:10.1016/S0092-8674(04)00419-2.
80. Xu, D., Alipio, Z., Fink, L.M., Adcock, D.M., Yang, J., Ward, D.C., and Ma, Y. 2009. Phenotypic correction of murine hemophilia A using an iPS cell-based therapy. Proc. Natl. Acad. Sci. U.S.A. 106 (3): 808-813. doi:10.1073/pnas.0812090106.
81. Yu, J., Hu, K., Smuga-Otto, K., Tian, S., Stewart, R., Slukvin, I.I., and Thomson, J.A. 2009. Human induced pluripotent stem cells free of vector and transgene sequences. Science, 324(5928): 797-801. doi:10.1126/science.1172482.
82. Zhou, W., and Freed, C.R. 2009. Reprogram human fibroblasts to induced pluripotent stem cells. Stem Cells, 27(11): 2667-2674. doi:10.1002/stem.201.
83. Zhou, H., Wu, S., Joo, J.Y., Zhu, S., Han, D.W., Lin, T., et al. 2009. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell, 4(5): 381-384. doi:10.1016/j.stem.2009.04.005.